Bayer submits Elinzanetant to EMA for non-hormonal menopause treatment
GERMANY—Bayer, the German pharmaceutical giant, has recently submitted a marketing authorisation...
Read MoreSelect Page
Oct 17, 2024
GERMANY—Bayer, the German pharmaceutical giant, has recently submitted a marketing authorisation...
Read MoreOct 6, 2024
GERMANY—Siemens Healthineers has teamed up with more than 20 industry and public partners,...
Read MoreSep 30, 2024
AUSTRIA — Pharmaceutical giant Boehringer Ingelheim has inaugurated a €60 million (US$66.8...
Read MoreSep 25, 2024
UGANDA—The Ugandan Ministry of Health has received a boost in its digitization efforts through a...
Read MoreSep 22, 2024
GERMANY—Boehringer Ingelheim, a global biopharmaceutical company known for its human and animal...
Read MoreAug 12, 2024
GERMANY— German-based pharmaceutical company STADA Arzneimittel AG is expanding its consumer...
Read MoreMar 6, 2024
GERMANY—NovAliX, a specialist Contract Research Organization focused on drug development, has...
Read MoreJan 14, 2024
GERMANY – Boehringer Ingelheim has invested €120 million (US$131.6 million) for the extension of...
Read MoreDec 10, 2023
GERMANY – Bayer has inaugurated a state-of-the-art manufacturing facility in Berlin, Germany,...
Read MoreDec 1, 2023
GERMANY — December 1 has marked World AIDS Day for 35 consecutive years, globally uniting efforts...
Read More